Valiant Lab IPO subscribed 2
时间:2024-06-16 22:31:51 阅读（143）
The Initial Public Offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories was subscribed 2.17 times on the third day of bidding on Friday.
The initial share sale received bids for 1,65,77,925 shares against 76,23,030 shares on offer, as per NSE data.
Price range for the offer is Rs 133-140 a share.
The IPO is an entirely fresh issuance of up to 1.08 crore equity shares.
Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd — and to meet the working capital requirements of the subsidiary company.
Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.
Unistone Capital is the manager to the offer.
Equity shares of the company will be listed on the BSE and the NSE.
猜你喜欢
- AAP sweeps away 15 year BJP reign in MCD election – Photos from celebrations
- Adani Group stocks continue to bleed
- Petrol and Diesel Rate Today, 20 March- Fuel prices unchanged; Check rates in Delhi, Mumbai, other cities
- Strong US Data, Hawkish Fed and Geopolitical Worries to Support Dollar Bulls
- 8 years of Startup India- How PM Modi’s pet startup initiative performed so far
- Strong performance in US market to support growth of Indian pharma industry in FY24- ICRA
- Tata Tech’s Rs 3,042
- 3 Adani group shares exit NSE’s short-term additional surveillance framework
- Suraj Estate Developers IPO subscribed 71 per cent on first day of subscription